Product Information
CLINDAMYCIN PH 1% SOLUTION is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.1788 per ML under NDC 45802056201. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Nov 30, 1995. Its Orange Book therapeutic-equivalence code is AT.
Strength
10 mg/mL
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802056201
Classification
Generic
Dosage Form
SOLUTION
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
CLINDAMYCIN PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA064050FDA Approved
11/30/1995
TE Code
AT
On Market Since
9/17/2013
Pharmacological Classes
Price Statistics
The NADAC for CLINDAMYCIN PH 1% SOLUTION has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 80.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1788 per ML |
|---|---|
| All-time high | $1.0283 (Oct 15, 2014) |
| All-time low | $0.1788 (Sep 23, 2026) |
| 52-week high | $0.2463 |
| 52-week low | $0.1788 |
| Median price | $0.3226 |
| Average price | $0.4726 |
| Largest weekly change | +55.2% (Mar 20, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 16% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Padagis Israel Pharmaceuticals Ltd manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Clindamycin Phosphate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Lincosamide Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLINDAMYCIN PH 1% SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for CLINDAMYCIN PH 1% SOLUTION, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.1788 per ML (NDC 45802056201), effective Sep 30, 2026.
How has the price of CLINDAMYCIN PH 1% SOLUTION changed over time?
Over the history we have for it, the NADAC for CLINDAMYCIN PH 1% SOLUTION has declined 80.8%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CLINDAMYCIN PH 1% SOLUTION?
Since Nov 28, 2013, the NADAC for CLINDAMYCIN PH 1% SOLUTION has ranged from a low of $0.1788 (Sep 23, 2026) to a high of $1.0283 (Oct 15, 2014), with a median of $0.3226 per ML.
Are there cheaper alternatives to CLINDAMYCIN PH 1% SOLUTION?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CLINDAMYCIN PH 1% SOLUTION, is $0.1499 per ML — about 16% below CLINDAMYCIN PH 1% SOLUTION.
Who manufactures CLINDAMYCIN PH 1% SOLUTION?
CLINDAMYCIN PH 1% SOLUTION (NDC 45802056201) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.